logo

AbCellera Biologics Inc (ABCL) Stock: A Comprehensive 52-Week Review

CROX

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. AbCellera Biologics Inc’s current trading price is -50.71% away from its 52-week high, while its distance from the 52-week low is 18.63%. The stock’s price range over this period has fluctuated between $2.34 and $5.62. The company, operating within the financial sector, had a trading volume of approximately 5.68 million for the day, which was noticeably higher than the average daily share volume of 2.61 million over the last 3 months.

In terms of market performance, AbCellera Biologics Inc had a fairly uneven. The highest value for the stock in the past year was $5.62 on 01/29/24, and the lowest value was recorded at $2.34 on 09/10/24.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

AbCellera Biologics Inc (ABCL) has experienced a quarterly rise of 6.95% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 818.17M and boasts a workforce of 586 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 2.75, with a change in price of +0.17. Similarly, AbCellera Biologics Inc recorded 2,407,408 in trading volume during the last 100 days, posting a change of +6.54%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for ABCL stands at 0.07. Similarly, the long-term debt-to-equity ratio is also 0.06.

ABCL Stock Stochastic Average

Today’s raw stochastic average for AbCellera Biologics Inc over the last 50 days is 27.98%.This indicates a increase from the raw stochastic average of the past 20 days, which was 17.75%. Moreover, the company’s Stochastic %K and %D values for the last 20 days were 32.74% and 39.97%, respectively.

ABCL Stock Price Performance Analysis

A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -5.46%. However, over the past six months, we’ve seen a stronger performance of -13.44%. The price of ABCL leaped by -4.81% over the last 30 days. And in the last five days, it has fallen by -16.31%.

Most Popular